» Articles » PMID: 19296888

Counterpoint: Hydroxyapatite Crystal Deposition is Not Intimately Involved in the Pathogenesis and Progression of Human Osteoarthritis

Overview
Publisher Current Science
Specialty Rheumatology
Date 2009 Mar 20
PMID 19296888
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The association of hydroxyapatite deposition with osteoarthritis pathogenesis and progression remains controversial, even after decades of study. Hydroxyapatite crystals are found in osteoarthritis in advanced disease only. Even then, hydroxyapatite crystals are found in such small amounts that special analytical techniques are required to detect the crystals. Further, the osteoarthritic joint fluid appears noninflammatory, suggesting that such hydroxyapatite crystals have very small effect on the pathologic process. Formal histopathologic evidence is scant, but hydroxyapatite crystal deposition within osteoarthritic synovium or cartilage is a rare event. Hydroxyapatite crystals may be present at end-stage osteoarthritis, but in insufficient amounts to contribute significantly to osteoarthritis pathogenesis or progression. This review critically examines the evidence from osteoarthritic synovial fluids, imaging, and histopathology to determine whether the well-characterized in vitro cellular reactions to hydroxyapatite apply to the pathogenesis of human osteoarthritis.

Citing Articles

Prevalence of intra-articular mineralization on knee computed tomography: the multicenter osteoarthritis study.

Jarraya M, Guermazi A, Liew J, Tolstykh I, Lynch J, Aliabadi P Osteoarthritis Cartilage. 2023; 31(8):1111-1120.

PMID: 37088266 PMC: 10524737. DOI: 10.1016/j.joca.2023.04.004.


The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.

Altomare A, Corrado A, Maruotti N, Cici D, Cantatore F Mol Biol Rep. 2021; 48(5):4789-4796.

PMID: 34075537 PMC: 8260411. DOI: 10.1007/s11033-021-06457-z.


Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography.

Tanikawa H, Ogawa R, Okuma K, Harato K, Niki Y, Kobayashi S J Orthop Surg Res. 2018; 13(1):73.

PMID: 29622016 PMC: 5887196. DOI: 10.1186/s13018-018-0787-0.


Matrix vesicles from chondrocytes and osteoblasts: Their biogenesis, properties, functions and biomimetic models.

Bottini M, Mebarek S, Anderson K, Strzelecka-Kiliszek A, Bozycki L, Simao A Biochim Biophys Acta Gen Subj. 2017; 1862(3):532-546.

PMID: 29108957 PMC: 5801150. DOI: 10.1016/j.bbagen.2017.11.005.


Rapidly Progressive Osteoarthritis: a Review of the Clinical and Radiologic Presentation.

Flemming D, Gustas-French C Curr Rheumatol Rep. 2017; 19(7):42.

PMID: 28689367 DOI: 10.1007/s11926-017-0665-5.


References
1.
Mitsuyama H, Healey R, Terkeltaub R, Coutts R, Amiel D . Calcification of human articular knee cartilage is primarily an effect of aging rather than osteoarthritis. Osteoarthritis Cartilage. 2007; 15(5):559-65. PMC: 2707182. DOI: 10.1016/j.joca.2006.10.017. View

2.
Molloy E, McCarthy G . Eicosanoids, osteoarthritis, and crystal deposition diseases. Curr Opin Rheumatol. 2005; 17(3):346-50. DOI: 10.1097/01.bor.0000155363.61120.c3. View

3.
Halverson P . Arthropathies associated with basic calcium phosphate crystals. Scanning Microsc. 1992; 6(3):791-6; discussion 796-7. View

4.
Steinbach L, Resnick D . Calcium pyrophosphate dihydrate crystal deposition disease revisited. Radiology. 1996; 200(1):1-9. DOI: 10.1148/radiology.200.1.8657894. View

5.
Cheung H . Biologic effects of calcium-containing crystals. Curr Opin Rheumatol. 2005; 17(3):336-40. DOI: 10.1097/01.bor.0000155362.83990.80. View